First Treatment Approved for Disease Linked to Stem Cell Transplant

WEDNESDAY, March 30, 2016 — Defitelio (defibrotide sodium) has been approved by the U.S. Food and Drug Administration to treat a rare, but usually fatal liver disease that affects some people who have had a stem cell transplant.
The condition,…
Source: Topamax